Flenodic 25 mg or 100 mg Tablets
PDF Leaflet Revision Date: 20 February 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of rheumatoid arthritis, osteoarthrosis, and pain associated with inflammation.
Dosage (summary)
Initial daily dose: 100-150 mg; for primary dysmenorrhoea: 50-150 mg.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Methotrexate
- Anticoagulants
- Diuretics
- Lithium
Contraindications
- Active peptic ulcer
- Hypersensitivity to diclofenac
- Asthma induced by NSAIDs
- Heart failure
- Pregnancy
- Lactation
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Headache
Counselling Points
- Take with food
- Monitor for gastrointestinal symptoms
- Avoid in pregnancy and breastfeeding
Serious warnings
- Gastrointestinal bleeding
- Cardiovascular events
- Serious skin reactions
Important Disclaimer
The Flenodic 25 mg or 100 mg Tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
